BioSpace News Archive

Axsome Therapeutics, Inc., a biopharmaceutical company developing novel therapies for the management of central nervous system disorders, announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation for AXS-05 for the treatment of Alzheimer’s disease agitation.

4th Annual $50,000 Research Grant to be Awarded to US-Based Researcher for the Study of Gut Microbiota and Chronic Disease

Universal digital operating system for surgery enables health tech companies & start-ups to accelerate, scale & grow

Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that it has been added to the Russell 2000® Index, effective as of market close today. The Russell 2000® Index measures the performance of the small-cap segment of the U.S. equity market. The index is a subset of the Russell 3000® Index and represents approximately 10

CSOFT Health Sciences, a leading provider of cross-border medical communications solutions, is pleased to announce Senior VP Dr. Nimita Limaye’s role as the new Regional Chair of DIA’s India Medical Writing Community

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

Xeris Pharmaceuticals, Inc. announced that on June 24, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 1,000 shares of its common stock to 2 new employees under Xeris’ Inducement Equity Plan.

MindMed Co-founders and Co-CEOs JR Rahn and Stephen Hurst to provide corporate update of activities and investor Q&A on July 2, 2020 at 1pm EDT

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced that earlier today it sued generic drug maker Apotex Inc. and Apotex Corp.

Quanta Inc. (OTC PINK:QNTA), an applied sciences company based on a quantum biology platform that significantly boosts the potency and efficiency of any plant-based matter, announced the launch of molequle, a new skincare brand initially featuring masks and under eye patches.